Genfit SA (GNFT)
4.50
-0.04
(-0.77%)
USD |
NASDAQ |
Nov 15, 16:00
4.42
-0.08
(-1.78%)
After-Hours: 20:00
Genfit Shares Outstanding: 49.91M for June 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
June 30, 2024 | 49.91M |
April 01, 2024 | 49.86M |
December 31, 2023 | 49.84M |
June 30, 2023 | 49.84M |
April 01, 2023 | 49.84M |
December 31, 2022 | 49.84M |
June 30, 2022 | 49.82M |
April 01, 2022 | 49.82M |
December 31, 2021 | 49.82M |
December 22, 2021 | 49.73M |
September 29, 2021 | 45.74M |
June 30, 2021 | 45.78M |
April 13, 2021 | 45.75M |
February 18, 2021 | 41.81M |
December 31, 2020 | 38.80M |
December 22, 2020 | 38.80M |
November 30, 2020 | 38.80M |
June 30, 2020 | 38.83M |
May 01, 2020 | 38.84M |
December 31, 2019 | 38.86M |
March 31, 2019 | 38.83M |
March 29, 2019 | 38.80M |
December 31, 2018 | 31.18M |
Date | Value |
---|---|
June 30, 2018 | 31.17M |
December 31, 2017 | 31.17M |
June 30, 2017 | 31.16M |
December 31, 2016 | 31.16M |
June 30, 2016 | 27.17M |
December 31, 2015 | 24.69M |
June 30, 2015 | 24.70M |
December 31, 2014 | 24.69M |
June 30, 2014 | 24.09M |
December 31, 2013 | 21.18M |
June 30, 2013 | 21.06M |
December 31, 2012 | 16.54M |
June 30, 2012 | 15.55M |
December 31, 2011 | 14.05M |
June 30, 2011 | 12.02M |
December 31, 2010 | 12.02M |
June 30, 2010 | 12.02M |
December 31, 2009 | 11.62M |
December 31, 2008 | 11.62M |
December 31, 2007 | 11.62M |
June 30, 2007 | 11.62M |
December 31, 2006 | 11.62M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
38.80M
Minimum
Dec 31 2020
49.91M
Maximum
Jun 30 2024
45.51M
Average
47.75M
Median
Shares Outstanding Benchmarks
Edap TMS SA | 37.10M |
DBV Technologies SA | 96.20M |
Cellectis SA | 100.09M |
Adaptimmune Therapeutics PLC | 255.88M |
Akari Therapeutics PLC | 11.95M |